Skip to main content

Market Overview

India Extends Shelf Life For AstraZeneca COVID-19 Jab To Nine Months: Reuters


India’s drug regulator has allowed AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine to be used for up to nine months from its manufacture date, versus the prescribed six months, according to a document reviewed by Reuters and a source.

  • The approval is expected to minimize vaccine wastage and better plan the inoculation programs.
  • Some Africa can use up more than a million doses of the branded Covishield vaccine by Serum Institute Of India by mid-next month if the shelf life is not extended.
  • “You are permitted to apply the shelf-life of nine months to unlabeled vials available on hand,” India’s drug controller-general, V.G. Somani, wrote late last month in reply to a request from the Serum Institute Of India.
  • AstraZeneca said that its shot could be stored, transported, and handled at normal refrigerated conditions for at least six months.
  • The World Health Organization website also gives the shelf-life of Covishield and the South Korean-made AstraZeneca shot as six months.
  • Each vial typically contains 5 milliliters of vaccine or ten doses.
  • The source did not specify what kind of data was shared by the company.
  • Somani, Serum Institute Of India, and AstraZeneca did not immediately respond.
  • Price Action: AZN shares are down 1.34% at $50.13 in premarket trading on the last check Tuesday.

Related Articles (AZN + AZNCF)

View Comments and Join the Discussion!

Posted-In: COVID-19 Vaccine India ReutersBiotech News Health Care FDA General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at